Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV000049961 | SCV002016788 | likely pathogenic | Cornea plana 2 | 2020-12-10 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000049961 | SCV004806742 | uncertain significance | Cornea plana 2 | 2024-03-26 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049961 | SCV000082370 | probable-pathogenic | Cornea plana 2 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |